CPMG Inc is Director & 10% Owner at REATA PHARMACEUTICALS INC (RETA). They have made 35 open-market trades across 3 companies since 2006, most recently 2024-05-03.
CIK 0001372218
35 open-market purchases totalling $109.1M since 2006, never a sale. Across 29 scored buys the stock is up 16.7% at ninety days, and 14.0 points ahead of the S&P over the same stretch.
29 scored purchases · one row per filing · discretionary only
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 48% | 52% | 62% |
| Avg Move | -0.8% | +9.5% | +16.7% |
| Alpha | -1.0% | +7.8% | +14.0% |
| Scored | 29 | 29 | 29 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| APEN | BUY | 2021-10-15 | 2021-10-19 | $7.75 | $3.3M | +4.0% | -3.2% | -38.2% |
| RETA | BUY | 2019-11-18 | 2019-11-18 | $183.00 | $7.4M | -7.1% | +1.5% | +8.6% |
| RETA | BUY | 2018-12-10 | 2018-12-12 | $59.41 | $6.6M | -22.1% | +15.6% | +51.6% |
| RETA | BUY | 2017-12-28 | 2017-12-28 | $26.10 | $5K | +5.8% | +7.5% | -26.7% |
| RETA | BUY | 2017-12-14 | 2017-12-15 | $24.65 | $1.6M | +4.7% | +11.9% | -10.8% |
| RETA | BUY | 2017-12-13 | 2017-12-15 | $24.88 | $2.5M | +4.7% | +11.9% | -10.8% |
| RETA | BUY | 2017-12-13 | 2017-12-28 | $24.78 | $1.7M | +5.8% | +7.5% | -26.7% |
| RETA | BUY | 2017-12-13 | 2017-12-15 | $24.76 | $6.8M | +4.7% | +11.9% | -10.8% |
| RETA | BUY | 2017-06-22 | 2017-06-23 | $25.00 | $30.0M | +8.6% | +21.8% | +8.6% |
| RETA | BUY | 2016-12-30 | 2017-01-04 | $21.72 | $116K | -4.5% | -0.1% | -2.8% |
| RETA | BUY | 2016-12-30 | 2017-01-04 | $21.72 | $292K | -4.5% | -0.1% | -2.8% |
| RETA | BUY | 2016-12-16 | 2016-12-20 | $22.99 | $7.5M | -5.5% | +0.2% | +19.2% |
| RETA | BUY | 2016-12-14 | 2016-12-16 | $21.37 | $60K | -5.9% | -4.4% | +17.8% |
| RETA | BUY | 2016-12-14 | 2016-12-16 | $21.57 | $384K | -5.9% | -4.4% | +17.8% |
| RETA | BUY | 2016-08-18 | 2016-08-18 | $17.32 | $1.8M | +7.0% | +68.0% | +77.1% |
| RETA | BUY | 2016-08-17 | 2016-08-18 | $17.26 | $2.4M | +7.0% | +68.0% | +77.1% |
| RETA | BUY | 2016-08-16 | 2016-08-18 | $16.21 | $932K | +7.0% | +68.0% | +77.1% |
| RETA | BUY | 2016-08-16 | 2016-08-18 | $17.08 | $8.8M | +7.0% | +68.0% | +77.1% |
| RETA | BUY | 2016-06-30 | 2016-06-30 | $19.75 | $2.0M | -13.4% | -20.1% | +24.2% |
| RETA | BUY | 2016-06-29 | 2016-06-30 | $19.83 | $1.3M | -13.4% | -20.1% | +24.2% |
| RETA | BUY | 2016-06-28 | 2016-06-30 | $19.78 | $4.5M | -13.4% | -20.1% | +24.2% |
| RETA | BUY | 2016-06-27 | 2016-06-28 | $19.17 | $367K | -21.3% | -21.5% | +12.6% |
| RETA | BUY | 2016-06-24 | 2016-06-28 | $19.19 | $1.7M | -21.3% | -21.5% | +12.6% |
| RETA | BUY | 2016-06-24 | 2016-06-28 | $19.41 | $838K | -21.3% | -21.5% | +12.6% |
| RETA | BUY | 2016-06-06 | 2016-06-08 | $17.57 | $710K | -18.1% | -20.1% | -3.0% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.